FDA Issues Class I Recall for COVID-19 At-Home Tests
This Class I recall is for certain COVID-19 at-home test kits containing liquid solution that may be contaminated with bacteria.
Read More
Search Results for: covid-19
Program Supports Need to Expand Diagnostic Testing Access
The CDC’s OneLab TEST is designed for anyone who performs or coordinates diagnostic testing at non-laboratory sites.
Read More
Cancer Screening Delays Due to COVID-19 Fuel Rise in Diagnoses
Delays in cancer screening during the COVID-19 pandemic will likely cause a significant increase in cancer cases.
Read More
Affordable At-Home Molecular Test for COVID-19, Flu-A, Flu-B & RSV Moving Closer
The award through the NIH’s RADx Tech program, will support Domus Diagnostics’ at-home molecular test for clinical trial readiness.
Read More
Regular Diagnostic Testing, Voluntary Isolation Favored Over Closures in Disease Outbreaks
Regular diagnostic testing and self-isolation can be more effective than school and business closures in combating disease outbreaks.
Read More